Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Bateman

Showing results (181-190 of 345) with videos related to

Pageof 35
Sort By:
Thorax|May 1, 2012
Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparisonDonald A Mahler, Anthony D'Urzo, Eric D Bateman, et al.
American Journal of Respiratory and Critical Care Medicine|October 27, 2004
Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthmaPaul M O'Byrne, Hans Bisgaard, Philippe P Godard, et al.
BMC Pulmonary Medicine|April 22, 2017
Efficacy of budesonide/formoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatmentChristine R Jenkins, Göran Eriksson, Eric D Bateman, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 6, 2010
Effect on tuberculosis outcomes of educational outreach to South African clinics during two randomised trialsM O Bachmann, L R Fairall, C Lombard, et al.
The British Journal of Dermatology|October 13, 2006
Poikiloderma, tendon contracture and pulmonary fibrosis: a new autosomal dominant syndrome?N P Khumalo, K Pillay, P Beighton, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|August 21, 2015
Fluticasone furoate (FF)/vilanterol (100/25 mcg or 200/25 mcg) or FF (100 mcg) in persistent asthmaDavid I Bernstein, Eric D Bateman, Ashley Woodcock, et al.
The European Respiratory Journal|January 2, 2010
Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPDR N van Zyl Smit, M Pai, W W Yew, et al.
The European Respiratory Journal|July 9, 2011
Roflumilast with long-acting β2-agonists for COPD: influence of exacerbation historyE D Bateman, K F Rabe, P M A Calverley, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 28, 2019
Global Initiative for Asthma 2016-derived asthma control with fluticasone propionate and salmeterol: A Gaining Optimal Asthma Control (GOAL) study reanalysisEric D Bateman, William Busse, Søren E Pedersen, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|May 13, 2010
Expanding access to ART in South Africa: the role of nurse-initiated treatmentChristopher J Colvin, Lara Fairall, Simon Lewin, et al.
Pageof 35

Showing results (181-190 of 345) with videos related to

Sort By:
Pageof 35
Thorax|May 1, 2012
Concurrent use of indacaterol plus tiotropium in patients with COPD provides superior bronchodilation compared with tiotropium alone: a randomised, double-blind comparisonDonald A Mahler, Anthony D'Urzo, Eric D Bateman, et al.
American Journal of Respiratory and Critical Care Medicine|October 27, 2004
Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthmaPaul M O'Byrne, Hans Bisgaard, Philippe P Godard, et al.
BMC Pulmonary Medicine|April 22, 2017
Efficacy of budesonide/formoterol maintenance and reliever therapy compared with higher-dose budesonide as step-up from low-dose inhaled corticosteroid treatmentChristine R Jenkins, Göran Eriksson, Eric D Bateman, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|February 6, 2010
Effect on tuberculosis outcomes of educational outreach to South African clinics during two randomised trialsM O Bachmann, L R Fairall, C Lombard, et al.
The British Journal of Dermatology|October 13, 2006
Poikiloderma, tendon contracture and pulmonary fibrosis: a new autosomal dominant syndrome?N P Khumalo, K Pillay, P Beighton, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|August 21, 2015
Fluticasone furoate (FF)/vilanterol (100/25 mcg or 200/25 mcg) or FF (100 mcg) in persistent asthmaDavid I Bernstein, Eric D Bateman, Ashley Woodcock, et al.
The European Respiratory Journal|January 2, 2010
Global lung health: the colliding epidemics of tuberculosis, tobacco smoking, HIV and COPDR N van Zyl Smit, M Pai, W W Yew, et al.
The European Respiratory Journal|July 9, 2011
Roflumilast with long-acting β2-agonists for COPD: influence of exacerbation historyE D Bateman, K F Rabe, P M A Calverley, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 28, 2019
Global Initiative for Asthma 2016-derived asthma control with fluticasone propionate and salmeterol: A Gaining Optimal Asthma Control (GOAL) study reanalysisEric D Bateman, William Busse, Søren E Pedersen, et al.
South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde|May 13, 2010
Expanding access to ART in South Africa: the role of nurse-initiated treatmentChristopher J Colvin, Lara Fairall, Simon Lewin, et al.
Pageof 35